Početna › Plućna hipertenzija › Utah
Kliničke studije za Plućna hipertenzija u državi Utah
7 studija za Plućna hipertenzija traži sudionike na lokacijama u državi Utah.
Gradovi u državi Utah
Službeni tekst studije (engleski)
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA025, Salt Lake City
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07179380Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Utah, Salt Lake City
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Intermountain Medical Center, Murray
- University of Utah Health, Salt Lake City
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 26. kol 2026. · NCT06388421De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
- University of Utah & Primary Children's Hospital (Utah-PCH), Salt Lake City
U tijeku regrutacijaFaza 4
0 Months – 1 Month · Oba spola · Ažurirano 18. kol 2026. · NCT05213676Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of Utah Hospital, Salt Lake City
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 10. lip 2026. · NCT06526195Pulmonary Hypertension Association Registry
- University of Utah Health, Salt Lake City
U tijeku regrutacijaOpažajna studija
Od 0 godina i više · Oba spola · Ažurirano 14. stu 2025. · NCT04071327A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
- Primary Children's Hospital, Salt Lake City
U tijeku regrutacijaFaza 2
Sve dobne skupine · Oba spola · Ažurirano 4. tra 2025. · NCT05201144Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.